dy of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic...

发表于 1 小时前

期刊：Journal of Clinical Oncology

文献作者：Erica L. Mayer; Yue Ren; Nikhil Wagle; Reshma Mahtani; Cynthia Ma; Angela DeMichele; Massimo Cristofanilli; Jane Meisel; Kathy D. Miller; Yara Abdou; Elizabeth C. Riley; Rubina Qamar; Priyanka Sharma; Sonya Reid; Natalie Sinclair; Meredith Faggen; Caroline C. Block; Naomi Ko; Ann H. Partridge; Wendy Y. Chen; Michelle DeMeo; Victoria Attaya; Amanda Okpoebo; Jillian Alberti; Yuan Liu; Eric Gauthier; Harold J. Burstein; Meredith M. Regan; Sara M. Tolaney

出版日期：2024-6-10

DOI号：10.1200/jco.23.01940

下载链接：https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.01940

文献链接：https://doi.org/10.1200/jco.23.01940

当前文献来源于 American Society of Clinical Oncology (ASCO)。

备注信息：

[其他期刊] dy of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic...

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[其他期刊] dy of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic... 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[其他期刊] dy of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic...